BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pre-Clinical Outsourcing

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing. The financ...

September 04, 2023 | News

Biocytogen Creates Divisions to Separate Preclinical Models and Antibody R&D

Biocytogen’s preclinical platforms include custom gene-editing services, generation of off-the-shelf humanized and/or immunodeficient animal and cell...

August 31, 2023 | News

Honeywell & Recipharm Accelerate Low-Warming Inhaler Development

Honeywell (Nasdaq: HON) and global contract development and manufacturing organization (CDMO) Recipharm have today announced a commercial p...

August 21, 2023 | News

Chime Biologics, Leads Biolabs, and BeiGene Join Forces to Advance LBL-007 mAb Globally

Leads Biolabs and Chime Biologics initiate strategic cooperation to accelerate IND application and provide clinical trial materials in China. BeiGe...

July 03, 2023 | News

WuXi Biologics to Increase Manufacturing Capacity in Germany

- The investment promotes the creation of additional high-skilled jobs - As part of WuXi Biologics' global manufacturing network, a new drug p...

June 02, 2023 | News

Vetter Expands Production Capacities and Services Offered at Its Austrian Site

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), continues to drive the expansion of capacities and services for the pr...

May 09, 2023 | News

Hummingbird Bioscience to showcase preclinical proof of concept for novel autoimmune disease antibody

HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ antibody-driven pathogenesis in lupus and cold agglutini...

May 09, 2023 | News

GenAssist's GEN6050 Base Editing Product Submits Pre-IND Application to FDA

Suzhou GenAssist Therapeutic Co.,Ltd recently announced its pre-IND application of their first base editing product, GEN6050 and the acceptance by the FDA....

May 08, 2023 | News

OBiO Technology Launches New Super Factory in Shanghai with 29 GMP-Grade Production Lines for Gene and Cell Therapy

At the opening ceremony, OBiO showed the holistic process development capability and large-scale GMP manufacturing capacity in variety gene and cell therap...

April 25, 2023 | News

Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line

"Receiving FDA approval on our HPAPI fill line is an exciting milestone for our company, and couldn't have happened without the hard work, hours of prepara...

April 20, 2023 | News

Crystal Formulation Services Receives China Drug Manufacturing License for Milestone Formulation Capability

Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was r...

April 20, 2023 | News

Catalent builds $20M expansion for German clinical supply facility

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has begun construction of ...

April 06, 2023 | News

Bridgewest Group launches NovaCina, new sterile injectable CDMO

The newly acquired facility and team is in Bentley, a suburb of Perth in Western Australia. It will operate as a Contract Development and Ma...

April 05, 2023 | News

Veranova Proposes Closure of Annan Facility 

Over the last several months, Veranova conducted a review of its manufacturing capacity relative to customer needs and market trends across its product por...

March 27, 2023 | News

Stay Connected